CD7 and neoplasm: The above-described strategies have been mostly based on the targeting of the main T lineage targets, such as CD1a, CD5, CD7, CD38, that, indeed, are shared by the normal T cell compartment and produce T-cell fratricide effects and severe T-cell aplasia as consequence of on-target/off-tumor cytotoxicity.